@article{Dore_2016,
title={Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials},
volume={64},
ISSN={0168-8278},
url={http://dx.doi.org/10.1016/j.jhep.2015.08.015},
DOI={10.1016/j.jhep.2015.08.015},
number={1},
journal={Journal of Hepatology},
publisher={Elsevier BV},
author={Dore,
Gregory J. and Conway,
Brian and Luo,
Yan and Janczewska,
Ewa and Knysz,
Brygida and Liu,
Yan and Streinu-Cercel,
Adrian and Caruntu,
Florin Alexandru and Curescu,
Manuela and Skoien,
Richard and Ghesquiere,
Wayne and Mazur,
Włodzimierz and Soza,
Alejandro and Fuster,
Francisco and Greenbloom,
Susan and Motoc,
Adriana and Arama,
Victoria and Shaw,
David and Tornai,
Istvan and Sasadeusz,
Joseph and Dalgard,
Olav and Sullivan,
Danielle and Liu,
Xuan and Kapoor,
Mudra and Campbell,
Andrew and Podsadecki,
Thomas},
year={2016},
month=jan,
pages={19–28} }